Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
US-2015366850-A1 · Dec 24, 2015 · US
US11285114B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11285114-B2 |
| Application number | US-201615771399-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2016 |
| Priority date | Oct 26, 2015 |
| Publication date | Mar 29, 2022 |
| Grant date | Mar 29, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein is a core-shell composite material comprising: a core optionally comprising an active ingredient compound; a shell structure comprising at least two alternating layers; the alternating layers being a protein layer and a polyphenol layer; and optionally a polyelectrolyte layer interfacing said core and said shell structure, said polyelectrolyte layer being disposed adjacent to said protein layer or said polyphenol layer, wherein said shell structure is selected to be resistant to degradation under gastric conditions but is degradable by one or more intestinal enzymes. In a preferred embodiment the protein is bovine serum albumin (BSA) or pepsin, the polyphenol layer is tannin or tannic acid, and the shell structure is degradable by pepsin.
Opening claim text (preview).
What is claimed is: 1. A core-shell composite material comprising: a. a core optionally comprising an active ingredient compound; b. a shell structure comprising at least two layers; said at least two layers being alternately a protein layer or a polyphenol layer; and c. a polyelectrolyte layer interposed between said core and said shell structure, wherein said shell structure is selected to be resistant to degradation under gastric conditions but is degradable by one or more intestinal enzymes, wherein said protein layer consists of a protein selected from alpha-s1-casein, pepsin, ovalbumin, lysozyme, hemoglobin from bovine blood, chymotrypsin, b-lactoglobulin, trypsin, ubiquitin, lectin, lactoperoxidase, myosin from rabbit muscle, actin, kappa-casein, beta-casein, alpha-lactalbumin, elastin from bovine neck ligament or ferritin, wherein said polyelectrolyte layer comprises a polyelectrolyte selected from poly(L-lysine), poly(L-arginine), dextran, starch, cellulose or derivatives thereof, wherein the outermost layer of said shell structure is a polyphenol layer, wherein said outermost polyphenol layer is characterized by being reactive with at least one gastric digestive enzyme to thereby bind a layer of said gastric digestive enzyme thereon or wherein each polyphenol layer is independently selected from, or is a derivative of, gallic acid, catechins, epicatechins, anthocyanidins, galloylated catechins, flavonoids, isoflavonoid, neoflavonoids, flavones, or tannins or wherein the outermost polyphenol layer is tannin, tannic acid or a derivative thereof and wherein the total thickness of the shell structure is 5 to 100 nm or wherein said core-shell composite material is spherical in shape and has a diameter of about 0.5 to about 10 μm. 2. The core-shell composite material of claim 1 , wherein said protein layer is resistant to proteolytic degradation by gastric digestive enzymes, characterized by having a ratio of residues cleavable by said gastric enzymes to total amino acid residues of less than 30% or wherein said gastric digestive enzyme is pepsin. 3. The core-shell composite material of claim 1 , wherein said protein layer is further characterized by having a ratio of total cleavable residues to total amino acid residues of more than 35%. 4. The c re-shell composite material of claim 1 , wherein said active ingredient is selected from the group consisting of: a pharmaceutically active compound or salt thereof, food additives, polysaccharides, a hormone, a bioactive, a protein, an enzyme, a peptide, a polypeptide, a prebiotic, a phytochemical, a probiotic, a vitamin and mixtures and complexes thereof. 5. The core-shell composite material of claim 1 , wherein said gastric conditions are characterized by about pH 3 and the presence of at least one gastric enzyme. 6. The core-shell composite material of claim 1 , wherein said one or more intestinal enzymes is one or more enzymes secreted from the pancreas or the small intestine selected from the group consisting of: trypsin, chymotrypsin, elastase, enterokinase, carboxypeptidase, aminopeptidase, dipeptidase and mixtures thereof. 7. A method of preparing a core-shell composite material comprising: (a) depositing, in alternate manner, at least one protein layer and at least one polyphenol layer to thereby form a shell structure enveloping an encapsulated active ingredient; wherein said at least one protein layer consists of a protein selected from alpha-s1-casein, pepsin, ovalbumin, lysozyme, hemoglobin from bovine blood, chymotrypsin, b-lactoglobulin, trypsin, ubiquitin, lectin, lactoperoxidase, myosin from rabbit muscle, actin, kappa-casein, beta-casein, alpha-lactalbumin, elastin from bovine neck ligament or ferritin, wherein said at least one protein layer is selected such that said shell structure is resistant to degradation under gastric conditions but is degradable by one or more intestinal enzymes, wherein said active ingredient is encapsulated by a polyelectrolyte selected from poly(L-lysine), poly(L-arginine), dextran, starch, cellulose or derivatives thereof prior to said deposition and wherein the depositing further comprises depositing the polyphenol layer as the outermost layer, wherein said outermost polyphenol layer is characterized by being reactive with at least one gastric digestive enzyme to thereby bind a layer of said gastric digestive enzyme thereon or wherein each polyphenol layer is independently selected from, or is a derivative of, gallic acid, catechins, epicatechins, anthocyanidins, galloylated catechins, flavonoids, isoflavonoid, neoflavonoids, flavones, or tannins or wherein the outermost polyphenol layer is tannin, tannic acid or a derivative thereof and wherein the total thickness of the shell structure is 5 to 100 nm or wherein said core-shell composite material is spherical in shape and has a diameter of about 0.5 to about 10 μm. 8. The method of claim 7 , wherein said active ingredient is absorbed on a solid support comprising a porous structure. 9. The method of claim 5 , wherein said at least one protein layer is resistant to proteolytic degradation by gastric digestive enzymes, characterized by having a ratio of residues cleavable by said gastric enzymes to total amino acid residues of less than 30%. 10. The method of claim 5 , wherein said protein layer is characterized by having a ratio of total cleavable residues to total amino acid residues of more than 35%. 11. The method of claim 8 , wherein the method further comprises removing said solid support prior to, during or after said deposition or wherein said removing comprises chemically decomposing said solid support. 12. The method of claim 7 , wherein the depositing (a) is a layer-by-layer deposition, comprising alternatingly mixing the active ingredient in a protein solution to form said at least one protein layer and subsequently mixing in a polyphenol solution to form a polyphenol layer over said at least one protein layer, to thereby form said shell structure or wherein the depositing comprises depositing the at least one protein layer adjacent to said polyelectrolyte layer wherein the depositing comprises depositing the at least one polyphenol layer adjacent to said polyelectrolyte layer. 13. A method of delivering an active ingredient to a desired location of a human or animal subject comprising administering a core-shell composite material to said subject, wherein said core-shell composite material encapsulates said active ingredient, wherein said core-shell composite material comprises: a. a core comprising the active ingredient; b. a shell structure comprising at least two layers; said at least two layers being alternately a protein layer or a polyphenol layer; and c. a polyelectrolyte layer interfacing said core and said shell structure, said polyelectrolyte layer being disposed adjacent to said protein layer or said polyphenol layer, wherein said shell structure is selected to be resistant to degradation under gastric conditions but is degradable by one or more intestinal enzymes, wherein said protein layer consists of a protein selected from alpha-s1-casein, pepsin, ovalbumin, lysozyme, hemoglobin from bovine blood, chymotrypsin, b-lactoglobulin, trypsin, ubiquitin, lectin, lactoperoxidase, myosin from rabbit muscle, actin, kappa-casein, beta-casein, alpha-lactalbumin, elastin from bovine neck ligament or ferritin, wherein said polyelectrolyte layer comprises a polyelectrolyte selected from poly(L-lysine), poly(L-arginine), dextran, starch, cellulose or derivatives thereof, wherein the outermost layer of said shell structure is a polyphenol layer, wherein said outermost polyphen
having two or more different coatings optionally including drug-containing subcoatings · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
Encapsulating processes; Filling of capsules (mechanical aspects A61J3/07) · CPC title
Coated capsules; Multilayered drug free capsule shells (with drug coating for immediate release A61K9/4808; osmotic devices A61K9/0004) · CPC title
Cellulose; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.